Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10003855719
Persistent link: https://www.econbiz.de/10009523918
Persistent link: https://www.econbiz.de/10009745132
In the aftermath of an array of economic failures, there is a growing movement to reform executive compensation. Concerned that executive compensation structures reward inappropriate risk taking and create a short-term perspective, the United States and the European Union are taking steps to...
Persistent link: https://www.econbiz.de/10013067371
A 2001 ruling by the Court of Appeals for the Ninth Circuit revives the controversy over whether partners and shareholders may be considered employees, entitled to protection under federal anti-discrimination laws. In Wells v. Clackamas, 271 F.3d 90, the Court of Appeals for the Ninth Circuit...
Persistent link: https://www.econbiz.de/10013070684
This article addresses the challenges of extraterritorial trademark protection in China, where the business and legal environments are quite at variance. The decisions surveyed include cases brought by: Anheuser-Busch, Nike, Starbucks, Dell, Bloomberg and so forth, where these companies assert...
Persistent link: https://www.econbiz.de/10013155433
This paper presents the background and the developing law of sexual harassment of the past thirty years. As women entered the workforce, propelled by the civil rights movement and economic factors, they began jobs that heretofore were the province of men and the first harassment cases appeared....
Persistent link: https://www.econbiz.de/10013155436
Persistent link: https://www.econbiz.de/10010085145
The National Collegiate Athletic Association (NCAA) is a powerful force in shaping the intercollegiate athletic programs of some 1,200 public and private colleges. Courts have recognized the NCAA as an entity that serves the important and admirable functions of maintaining the amateur status of...
Persistent link: https://www.econbiz.de/10014202547
The author reviews the pharmaceutical industry's patenting process as it has been impacted by the Hatch-Waxman and Medicare legislation which expedite review and approval for generic follow-on drugs. The pharmaceutical industry's business model of investment in research and development to create...
Persistent link: https://www.econbiz.de/10014202549